Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350919
Max Phase: Preclinical
Molecular Formula: C39H40N8O15P2
Molecular Weight: 922.74
Molecule Type: Small molecule
Associated Items:
ID: ALA3350919
Max Phase: Preclinical
Molecular Formula: C39H40N8O15P2
Molecular Weight: 922.74
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc(C(=O)N[C@@H]2[C@H](O)[C@@H](COP(=O)(O)OP(=O)([O-])O[C@H]3O[C@@H]([n+]4cccc(C(N)=O)c4)[C@H](O)[C@@H]3O)O[C@H]2n2cnc3c(NCc4cccc5ccccc45)ncnc32)c1
Standard InChI: InChI=1S/C39H40N8O15P2/c1-57-25-12-5-9-22(15-25)36(52)45-28-30(48)27(18-58-63(53,54)62-64(55,56)61-39-32(50)31(49)38(60-39)46-14-6-11-24(17-46)33(40)51)59-37(28)47-20-44-29-34(42-19-43-35(29)47)41-16-23-10-4-8-21-7-2-3-13-26(21)23/h2-15,17,19-20,27-28,30-32,37-39,48-50H,16,18H2,1H3,(H5-,40,41,42,43,45,51,52,53,54,55,56)/t27-,28-,30-,31-,32+,37-,38-,39-/m1/s1
Standard InChI Key: YTHNHXPIEXZICS-CWFIGKTDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 922.74 | Molecular Weight (Monoisotopic): 922.2088 | AlogP: 0.94 | #Rotatable Bonds: 16 |
Polar Surface Area: 325.20 | Molecular Species: ACID | HBA: 19 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.73 | CX Basic pKa: 4.70 | CX LogP: -5.25 | CX LogD: -6.72 |
Aromatic Rings: 6 | Heavy Atoms: 64 | QED Weighted: 0.05 | Np Likeness Score: 0.08 |
1. Kennedy KJ, Bressi JC, Gelb MH.. (2001) A disubstituted NAD+ analogue is a nanomolar inhibitor of trypanosomal glyceraldehyde-3-phosphate dehydrogenase., 11 (2): [PMID:11206479] [10.1016/s0960-894x(00)00608-9] |
Source(1):